Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AT&T Inc. (T) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

AT&T Inc.Trade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

AT&T Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? AT&T Inc. trades at $22.3 (market cap $152.52B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: AT&T Inc. pays a 5.06% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, AT&T Inc. nearer its low. Which is the better fit depends on your goals.

TXBI
Market Cap
$152.52B
Sector
MediaBroad Market / Factor
52-Week High
$29.62$164.28
52-Week Low
$20.49$85.16
Enterprise Value
$297.87B
Dividend Yield
5.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AT&T Inc.

AT&T (T) trades at $22.26, up 2.13% with a bullish technical signal despite mixed moving averages. The stock shows strong fundamentals with a low P/E of 7.39, robust profitability margins (net margin 16.94%), and consistent earnings beats in recent quarters. Recent cash flow improvement to $15.12B in 2025 and declining debt-to-asset ratio to 32.59% in 2024 signal financial health. The company faces competitive pressures in telecom but benefits from fiber expansion and stable wireless pricing.

Outlook remains positive with analyst consensus target of $25.61 offering 15% upside. Key opportunities include dividend yield support and fiber growth, while risks involve intense telecom competition and potential earnings volatility. Wall Street sentiment is cautiously optimistic with 41% buy ratings, though technical indicators show some overbought conditions near-term.

State Street SPDR S&P Biotech ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AT&T Inc.

AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.

Read more on T

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI